Back to results
US 5,312,925 AGranted
Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dih ydro-2H-indol-2-one-hydrochloride
AssigneePfizer Inc.
InventorsDouglas J. M. Allen, Frank R. Busch, Sabeto A. DiRoma, Dennis M. Godek
Life of this patent
Estimating the term…
Abstract
The monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydr o-2H-indole-2-one hydrochloride has advantageous stability for formulation as a neuroleptic agent.
Claims4
5-(2-( 4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-in dol-2-one hydrochloride monohydrate.
Dependencies are inferred from the claim text.